Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2970)
  2. Department of Medicine (2970)
  3. Hematologic Malignancies, Division of (2847)
  4. Survivorship Research (1388)
  5. GSK Faculty (931)
  6. CTCR Scholars (873)

More Groups

People
  1. Sergio Giralt (1068)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (67)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2970)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, double blind, placebo-controlled trial of a TNF inhibitor (ETANERCEPT) for the treatment of idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) study
    Meeting Abstract

    Yanik, G.; Ho, V. T.; Horowitz, M.; Weisdorf, D. J.; Logan, B. R.; Wu, J.; Soiffer, R. J.; Wingard, J. R.; Levine, J. E.; Ferrara, J. L. M.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Incidence and kinetics of CMV infection after T-cell depleted and unmodified allogeneic hematopoietic stem cell transplantation: A 10-year experience at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Xiao, K.; Jongwutiwes, U.; Chung, D.; Jakubowski, A. A.; Papanicolaou, G.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Hassoun, H.; Lendvai, N.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Feasibility of low dose azacitidine post T cell depleted allogeneic hematopoietic stem cell transplants in patients with myeloid malignancies at high risk for relapse
    Meeting Abstract

    Tamari, R.; Ponce, D.; Jakubowski, A. A.; Giralt, S. A.; Young, J.; Castro-Malaspina, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • High dose therapy and autologous stem cell transplantation results in good outcomes and acceptable toxicities in elderly patients with non-Hodgkin's lymphoma
    Meeting Abstract

    Tamari, R.; Dahi, P.; Devlin, S.; Goldberg, J.; Hamlin, P.; Matasar, M.; Maragulia, J.; Perales, M. A.; Moskowitz, C. H.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Vaccine responses following unrelated double cord blood transplantation (CBT)
    Meeting Abstract

    Small, T.; Lubin, M.; Scaradavou, A.; Iovino, C.; Bushnell, M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Stress testing prior to allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Pham, A.; Amoruso, D.; Nguy, S.; Stillwell, E. E.; Wessler, J. D.; Rebolledo, B. J.; Steingart, R. M.; Jakubowski, A. A.; Schaffer, W. L.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Dose intensification of busulfan in the preparative regimen is associated with improved outcomes: A phase I/II controlled, randomized study
    Meeting Abstract

    Parmar, S.; Rondon, G.; de Lima, M.; Thall, P.; Bassett, R.; Anderlini, P.; Kebriaei, P.; Champlin, R. E.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • High dose therapy improves survival in systemic light chain amyloidosis
    Meeting Abstract

    Parmar, S.; Howell, J.; Wang, M.; Khan, M.; Bashir, Q.; Shah, N.; Shah, J.; Popat, U.; Dinh, Y.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • BK virus-associated nephropathy (BKVN), an under-recognized cause of renal dysfunction in severely immunosuppressed hematopoietic stem cell transplant (HSCT) patients: Report of 5 cases of BKVN and the potential role of CMX001 for treatment
    Meeting Abstract

    Papanicolaou, G.; Kolitsopoulos, Y.; Young, J.; Boruchov, A.; Sankaranarayanan, N.; Hull, D.; Glezerman, I.; Mommeja-Marin, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save